Corona treatment refers to the medical approaches used to manage COVID-19, ranging from prescription antivirals for high-risk patients to basic symptom relief at home. Most people with mild illness recover with rest, fluids, and over-the-counter fever reducers. For those at higher risk of severe disease, antiviral medications can significantly reduce the chance of hospitalization when started early, ideally within five days of symptoms appearing.
Mild COVID-19: What You Can Do at Home
The majority of COVID-19 cases are mild, meaning you have symptoms like fever, cough, body aches, and fatigue but don’t need supplemental oxygen. Standard over-the-counter pain relievers and fever reducers are the backbone of home care. Staying hydrated, resting, and monitoring your symptoms is usually enough.
The key threshold to watch: if your blood oxygen level drops to 93% or below at rest, or your breathing rate climbs above 30 breaths per minute, that signals a shift from mild to severe illness. A cheap pulse oximeter can help you keep track at home. Persistent chest pressure, confusion, or an inability to stay awake are also signs you need emergency care.
Antiviral Medications for High-Risk Patients
If you’re at higher risk of getting seriously ill, prescription antivirals can shorten your illness and reduce the odds of hospitalization. Three antiviral treatments are currently authorized or approved by the FDA, and timing matters for all of them.
Paxlovid (nirmatrelvir with ritonavir) is the most widely used oral antiviral. It’s approved for adults and children 12 and older (weighing at least 88 pounds). You take it at home as a pill, and treatment must begin within five days of your first symptoms. Paxlovid works by blocking the virus’s ability to copy itself, but it interacts with a long list of other medications. If you take certain blood thinners, heart medications, some antidepressants, cholesterol-lowering statins, immunosuppressants, or corticosteroids, Paxlovid may not be safe for you without adjustments. Your prescriber will review your full medication list before writing the prescription. It’s also not recommended for people with severe kidney or liver problems.
Molnupiravir (Lagevrio) is another oral option, but it’s restricted to adults 18 and older. In clinical trials, it reduced the combined risk of hospitalization or death by about 30% compared to placebo. That’s a more modest benefit than Paxlovid, so it’s generally considered a second-line choice. Molnupiravir carries a significant warning for pregnancy: animal studies showed it can cause fetal harm, so it’s not recommended for pregnant individuals. Women of childbearing age should use effective contraception during treatment and for four days after the last dose. Breastfeeding should also be paused during that same window.
Remdesivir (Veklury) is available for both adults and children, but it requires three consecutive days of intravenous infusions at a healthcare facility, which makes it less convenient. Treatment must start within seven days of symptom onset. For outpatients, the three-day course is the standard regimen.
Who Qualifies as High Risk
Antiviral treatment is targeted at people most likely to develop severe COVID-19. There’s no single checklist, but well-established risk factors include older age, obesity, diabetes, chronic lung disease, heart disease, kidney disease, weakened immune systems (from conditions like cancer or organ transplant), and pregnancy. Your doctor evaluates your individual medical history to decide whether antiviral treatment makes sense.
If you think you qualify, speed matters. The biggest mistake people make is waiting too long to get tested or seek treatment. Antivirals work best when the virus is still actively replicating in the early days of infection. By the time someone is sick enough to need the hospital, antivirals alone are far less effective.
Hospital Treatment for Severe Cases
Patients who need supplemental oxygen or are hospitalized enter a different treatment tier. Remdesivir is the only antiviral recommended for hospitalized patients, typically given as a five-day intravenous course (or until discharge, whichever comes first). It’s used across a range of severity levels, from patients not yet needing oxygen to those on high-flow oxygen devices.
The other critical hospital treatment is dexamethasone, a corticosteroid that tamps down the overactive immune response that drives severe COVID-19 lung damage. The standard regimen is 6 mg daily for up to 10 days. This drug made a major difference early in the pandemic and remains a cornerstone of inpatient care. For patients on high-flow oxygen or ventilators, dexamethasone is often combined with remdesivir and additional immune-modulating medications.
One important detail: for patients who have progressed to the point of needing mechanical ventilation or the most extreme form of life support (ECMO), remdesivir is generally not recommended, as the evidence hasn’t shown a clear benefit at that stage.
Why Monoclonal Antibodies Are No Longer Used
Earlier in the pandemic, monoclonal antibody infusions were a major treatment option. These lab-made proteins mimicked the immune system’s ability to neutralize the virus. However, as the Omicron variant and its many sublineages emerged, each major antibody therapy lost its effectiveness one by one. Sotrovimab worked against early Omicron but failed against BA.2 and later subvariants. Bebtelovimab held up longer but couldn’t neutralize the BQ.1 and BQ.1.1 subvariants that became dominant. All previously authorized monoclonal antibody treatments for COVID-19 have had their authorizations revoked, and none are currently recommended.
Long COVID and Ongoing Symptoms
Some people develop persistent symptoms weeks or months after their initial infection, a condition known as Long COVID. There is no single diagnostic test for it. Doctors diagnose it based on your symptom history and a physical exam, sometimes supplemented by targeted testing to rule out other causes. A prior positive COVID test can support the diagnosis but isn’t strictly required.
Symptoms of Long COVID overlap with several other conditions, including chronic fatigue syndrome, fibromyalgia, and disorders of the autonomic nervous system (which controls heart rate, blood pressure, and digestion). Treatment is symptom-focused rather than one-size-fits-all. That might mean a rehabilitation plan for exercise intolerance, medication adjustments for sleep or pain, or strategies for managing brain fog and fatigue. Pacing activities to avoid post-exertional crashes is a common recommendation.
One of the most important parts of Long COVID care is simply having your symptoms taken seriously. Keeping a symptom diary that tracks what you experience day to day, what makes things better or worse, and how your function changes over time gives both you and your healthcare provider a clearer picture to work from.